BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Ipilimumab
1
Tsunami of immunotherapy reaches mesothelioma
4/22/2022 8:49:02 AM | Browse: 853 | Download: 1894
2
Immune checkpoint inhibitors induced colitis, stay vigilant: A case report
6/15/2020 8:19:14 AM | Browse: 1298 | Download: 2323
3
Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report
10/25/2019 8:06:40 AM | Browse: 1039 | Download: 2056
4
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
1/21/2019 9:20:19 AM | Browse: 1647 | Download: 2351
5
Endoscopic evaluation of immunotherapy-induced gastrointestinal toxicity
12/21/2018 6:09:14 AM | Browse: 1232 | Download: 2238
6
Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis
3/19/2017 6:44:00 PM | Browse: 1616 | Download: 3353
7
Ipilimumab associated colitis: An IpiColitis case series at MedStar Georgetown University Hospital
4/15/2015 11:01:00 AM | Browse: 1520 | Download: 2197
8
Present and future of immune checkpoint blockade: Monotherapy to adjuvant approaches
3/31/2015 10:55:00 AM | Browse: 1506 | Download: 1814
9
Diarrhoea in a patient with metastatic melanoma: Ipilimumab ileocolitis treated with infliximab
9/5/2014 2:19:00 PM | Browse: 1318 | Download: 1299
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.